Radiotherapy Clinics of Georgia (RCOG) is a renowned cancer treatment facility affiliated with The US Oncology Network and backed by McKesson Specialty Health. Since its establishment in 1984, RCOG has built a sterling reputation for its commitment to quality, cutting-edge radiation technology, and research focus. Specializing in treating various cancer types, including breast, prostate, gynecological, head, neck, lung, colon, thoracic, and lymphatic malignancies, RCOG offers state-of-the-art therapies such as IGRT, IMRT, Brachytherapy, SRS, SBRT, and HDR treatments.
Notably, it has emerged as an Atlanta-area leader in radiation therapy and has administered ProstRcision®, a prostate cancer treatment, to over 17,000 menclinics in Decatur, Snellville, Covington, and Conyers, all accredited by the American College of Radiology and staffed with a multidisciplinary team, including board-certified radiation oncologists, therapists, nurses, medical physicists, dosimetrists, and nutritional counselors.
Moreover, RCOG provides on-site assistance for financial counseling and payment support for patients. With its strong foothold in the Health Care and Health & Wellness industries, RCOG stands out as a significant player in the cancer treatment and research domain, making it an attractive potential investment opportunity for venture capitalists seeking exposure in the healthcare sector. However, further details on the company's recent investment activities and investors are currently unavailable.
There is no investment information
No recent news or press coverage available for Radiotherapy Clinics of Georgia (RCOG).